Sisram Medical Ltd (SRAMF) Stock Price, Trades & News

Sisram Medical Ltd is an investment holding company specializing in medical technology for healthcare. The Company is involved in research, development, design, manufacture, sale and marketing of medical aesthetics and dental equipment, home use devices, injectables and cosmeceuticals products. The company's products include Soprano Titanium, Colibri technology, and others. Some of the company's brands are Alma, Soprano, Copulla, and LMNT. It operates through the following geographical segments: North America which is its key revenue generating market, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Financial Strength

8/10

Name	Current	Vs Industry
Cash-To-Debt	1.37
Equity-to-Asset	0.73
Debt-to-Equity	0.11
Debt-to-EBITDA	1.62
Interest Coverage	10.02
Piotroski F-Score	4/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	1.94	Distress Grey Safe
Beneish M-Score	-2.28	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

5/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	0.9
	3-Year EBITDA Growth Rate	-5.7
	3-Year EPS without NRI Growth Rate	-22.2
	3-Year Book Growth Rate	3.6

Momentum Rank

6/10

	Name	Current	Vs Industry		Vs History
	9-Day RSI	0.01
	14-Day RSI	0.5
	6-1 Month Momentum %	-28.32
	12-1 Month Momentum %	-83.33

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	2.6
	Quick Ratio	1.72
	Cash Ratio	0.67
	Days Inventory	211.96
	Days Sales Outstanding	86.87
	Days Payable	46.71

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	3.69
	Dividend Payout Ratio	0.39
	3-Year Dividend Growth Rate	-7.1
	Forward Dividend Yield %	3.69
	5-Year Yield-on-Cost %	5.81
	3-Year Average Share Buyback Ratio	-0.1
	Shareholder Yield %	1.53

Profitability Rank

8/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	58.89
	Operating Margin %	8.9
	Net Margin %	5.2
	EBITDA Margin %	8.7
	FCF Margin %	1.87
	OCF Margin %	2.57
	ROE %	4.09
	ROA %	2.98
	ROIC %	5.43
	3-Year ROIIC %	-22.71
	ROC (Joel Greenblatt) %	20.34
	ROCE %	5.9
	Years of Profitability over Past 10-Year	10

GF Value Rank

4/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	7.07
	Forward PE Ratio	8.77
	PE Ratio without NRI	7.07
	Shiller PE Ratio	4.78
	PEG Ratio	1.14
	PS Ratio	0.37
	PB Ratio	0.28
	Price-to-Tangible-Book	0.63
	Price-to-Free-Cash-Flow	20
	Price-to-Operating-Cash-Flow	14.45
	EV-to-EBIT	4.37
	EV-to-EBITDA	4.37
	EV-to-Revenue	0.38
	EV-to-FCF	20.62
	Price-to-GF-Value	0.46
	Price-to-Projected-FCF	0.25
	Price-to-DCF (Earnings Based)	0.72
	Price-to-DCF (FCF Based)	2.58
	Price-to-Peter-Lynch-Fair-Value	1.15
	Price-to-Graham-Number	0.44
	Price-to-Net-Current-Asset-Value	1.37
	Earnings Yield (Greenblatt) %	22.88
	FCF Yield %	5.01
	Forward Rate of Return (Yacktman) %	13.95

GF Value™: $0.95

SRAMF

Warning Signs

Warning! GuruFocus detected 1 Severe warning sign with SRAMF. Try a 7-Day Free Trial to check it out.

Sisram Medical Ltd Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Sisram Medical Ltd Stock Events

Financials Calendars

	Event	Date	Price ($)
	HKD 0.126000 Cash Dividend	2025-08-26	0.55 (+0.00%)
	HKD 0.158000 Cash Dividend	2024-08-26	3.60 (+0.00%)

Show

Entries

Guru Commentaries on OTCPK:SRAMF

No articles.

Press Release

	Subject	Date
No Press Release

Articles on Sisram Medical Ltd

No articles.

Headlines

No news.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.